LFR: Glucose Dehydrogenase, Glucose
What it covers
A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.
The identification in 21 CFR 862.1345, glucose test system. FDA gives LFR no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K152328 | FreeStyle InsuLinx Blood Glucose Monotioring System | Abott Laboratories | Sep 17, 2015 | Special |
| K142089 | ACCU-CHEK AVIVA EXPERT SYSTEM | Roche Diagnostics Corporation | Dec 17, 2014 | Traditional |
| K133537 | EGV1.1 SELF MONITORING BLOOD GLUCOSE SYSTEM AND EGV1.1 PRO MONITORING BLOOD GLUCOSE SYSTEM | Eps Bio Technology Corp. | Apr 28, 2014 | Special |
| K131727 | CERA-CHEK 1070 BLOOD GLUCOSE MONITORING SYSTEM | Ceragem Medisys, Inc. | Feb 28, 2014 | Traditional |
| K131366 | ACCU-CHEK AVIVA EXPERT BLOOD GLUCOSE MONITORING SYSTEM | Roche Diagnostics Operations, Inc. | Oct 11, 2013 | Traditional |
| K122688 | NOVA MAX MINI BLOOD GLUCOSE AND B-KETONE MONITOR | Nova Biomedical Corporation | Apr 4, 2013 | Traditional |
| K121433 | GOODLIFE CS-200 (SINGLE PATIENT USE), CS-200 PROFESSIONAL (MULTIPLE PATIENT USE) BLOOD GLUCOSE MONITORING SYSTEMS | Hmd Biomedical, Inc. | Feb 14, 2013 | Traditional |
| K122435 | NOVA ONE BLOOD GLUCOSE MONITOR | Nova Biomedical Corporation | Dec 20, 2012 | Traditional |
| K113314 | PRECICHEK NS-101 POCT PROFESSIONAL BLOOD GLUCOSE MONITORING SYSTEM | Hmd Biomedical, Inc. | Nov 9, 2012 | Traditional |
| K121224 | GENESIS HEALTH TECHNOLOGIES BLOOD GLUCOSE MONITORING SYSTEM | Taidoc Technology Corporation | Sep 19, 2012 | Special |
Clearances by year
26 LFR 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2015 | 1 | 30 |
| 2014 | 3 | 161 |
| 2013 | 3 | 212 |
| 2012 | 13 | 152 |
| 2011 | 6 | 296 |
Who submits
13 applicants cleared a LFR device since 2011. 50% of the clearances went to applicants in Taiwan, then United States (42%), Switzerland (4%) and South Korea (4%). By type: Traditional 65% and Special 35%.
| Applicant | Clearances since 2011 |
|---|---|
| Eps Bio Technology Corp. | 6 |
| Taidoc Technology Corporation | 4 |
| Hmd Biomedical, Inc. | 3 |
| Bayer Healthcare | 2 |
| Bayer Healthcare, LLC | 2 |
| Nova Biomedical Corporation | 2 |
| Abbott Laboratories | 1 |
| Abott Laboratories | 1 |
How FDA classifies it
Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
From 21 CFR 862.1345. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 862.1345 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LFR clearances declared.
Ask about LFR
Questions about LFR
What is FDA product code LFR?
Product code LFR, “Glucose Dehydrogenase, Glucose” in FDA's classification database, is a Class II device type under 21 CFR 862.1345 (glucose test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 73 clearances under LFR, 26 of them since 2011.
How many 510(k) clearances are there under LFR?
FDA’s 510(k) database listed 73 clearances under LFR as of Oct 29, 2026, 26 of them decided since 2011; the most recent decision was Sep 17, 2015. The Predicate Finder searches the live database.
Which companies have the most LFR clearances?
Since 2011: Eps Bio Technology Corp. (6), Taidoc Technology Corporation (4), Hmd Biomedical, Inc. (3), Bayer Healthcare (2) and Bayer Healthcare, LLC (2). 13 applicants have cleared a LFR device in that time.